Fairmont Empress Victoria Floorplan
Registered Attendees
Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:
- Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting
(You can edit your own abstract from My Account page as well)
NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.
- Full participant list, including joint meeting participants
- Printable Invoices and Invitation Letters
- Scholarship Information
- Lodging Information
Login to My Account page
- Meeting Program
- Meeting Summary
- Abstract Information
- Registration Information
- Scholarships / Awards
- Lodging / Hotels
- Travel / Transportation
- Conference Location
- Things to Do
- Services
- My Account
NOTES:
This meeting occurs in 2019.
This meeting will be conducted in English.
All programs are subject to change. Check this site for updates.
Download Flyer
Twitter hashtag for this meeting: #KSgenome
This meeting occurs in 2019.
This meeting will be conducted in English.
All programs are subject to change. Check this site for updates.
Download Flyer
Twitter hashtag for this meeting: #KSgenome
Genome Engineering: From Mechanisms to Therapies (B4)
Scientific Organizers: Andrew May, Rodolphe Barrangou and Knut Woltjen
February 19—23, 2019
Fairmont Empress Victoria, Victoria, British Columbia, Canada
Sponsored by BlueRock Therapeutics, Editas Medicine and Thermo Fisher Scientific Inc.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.
DEADLINES:Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Deadline: Oct 23, 2018 [details]
Discounted Abstract Deadline: Oct 23, 2018 [details]
Abstract Deadline: Nov 20, 2018 [details]
Discounted Registration Deadline: Dec 19, 2018 [details]
Click here to view Cancellation Policy
Discounted Abstract Deadline: October 23, 2018
*All deadlines end at 11:59 PM US Mountain Standard TimeAbstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register
Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.
Submitting your abstract early allows us to:
- submit your abstract to organizers to be considered for a short talk
- accept your abstract online
- include your abstract on our website and in our secure mobile app
- reserve your space at the meeting for a poster presentation.**
(The Abstract Deadline: is November 20, 2018)
Global Health Travel Award Deadline:
*All deadlines end at 11:59 PM US Mountain Standard Time
Global Health Travel Award Details:
You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline
and complete the other required steps (verify your contact information and submit a recommendation letter)
to be considered for a travel award.
Click here to learn more about Global Health Travel Awards.
Scholarship Deadline: October 23, 2018
*All deadlines end at 11:59 PM US Mountain Standard Time
Scholarship Details:
You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.
Abstract Deadline: November 20, 2018
*All deadlines end at 11:59 PM US Mountain Standard Time
Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register
Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.
Submitting your abstract by the Abstract Deadline allows us to:
- submit your abstract to organizers to be considered for a short talk
- include your abstract on our website and in our secure mobile app
- reserve your space at the meeting for a poster presentation.**
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.
(Discounted Abstract Deadline: is October 23, 2018)
Discounted Registration Deadline: December 19, 2018
*All deadlines end at 11:59 PM US Mountain Standard Time
Registration Fee: 945.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 720.00 USD* (must complete student verification form)
*Includes 50.00 USD of your abstract submission fee
After the Discounted Registration Deadline:
Registration Fee: 1145.00 USD*
Student Registration Fee: 920.00 USD* (must complete student verification form)
*Includes 50.00 USD of your abstract submission fee
Registration spaces are limited and may fill prior to discounted registration deadline.
Please be advised that some meeting participants have received calls and emails from a number of different housing services,
including "Exhibitors Housing Services," “Expo Housing Services,” "Global Housing," etc. THESE COMPANIES ARE NOT AFFILIATED
WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting
is filling, without any actual knowledge to that effect, and pressure you into giving them your credit card number to make a
lodging reservation with them.
We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report any calls or correspondence you might have received to Keystone Symposia and book only through lodging links in your Keystone Symposia account, an established travel agency or directly with the hotel(s) listed on our website.
No registration fees are used to fund entertainment or alcohol at this conference
The meeting will begin on Tuesday, February 19 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Saturday, February 23 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Sunday, February 24 in order to fully experience the meeting.
TUESDAY, FEBRUARY 19
WEDNESDAY, FEBRUARY 20
THURSDAY, FEBRUARY 21
FRIDAY, FEBRUARY 22
SATURDAY, FEBRUARY 23
SUNDAY, FEBRUARY 24
Conference Program Print | View meeting in 12 hr (am/pm) time
The meeting will begin on Tuesday, February 19 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Saturday, February 23 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Sunday, February 24 in order to fully experience the meeting.
TUESDAY, FEBRUARY 19
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.
08:30—09:30
Philip D. Gregory,
Bluebird Bio, USA
Talk Title to be Announced
Talk Title to be Announced
09:30—11:45
Genome Engineering Tools and Technologies
Registered attendees can view abstracts starting on 01/19/2019
Registered attendees can view abstracts starting on 01/19/2019
Prashant Mali,
University of California, San Diego, USA
Therapeutic Strategies via Genome Engineering: New Approaches and New Challenges
Therapeutic Strategies via Genome Engineering: New Approaches and New Challenges
Coffee Break
Zoltan Ivics,
Paul Ehrlich Institute, Germany
Transposons: Molecular Parasites Tamed for Advanced Genome Engineering
Transposons: Molecular Parasites Tamed for Advanced Genome Engineering
Alexis C. Komor,
University of California, San Diego, USA
Early Career Talk: Using Uracil as a Genome Editing Intermediate
Early Career Talk: Using Uracil as a Genome Editing Intermediate
Short Talk(s) Chosen from Abstracts
14:30—16:30
Workshop 1: Tools and Technologies
A collection of short talks chosen from the abstracts discussing exciting new approaches and techniques being developed for the engineering of genomes. The workshop would cover topics including computational approaches to design and analysis of experiments, harnessing DNA repair mechanisms for improved engineering, epigenome editing, screening methods and engineering of DNA binding and modifying proteins.
Short Talks Chosen from Abstracts
17:00—19:00
Structure and Mechanism of Genome Editing Systems
Registered attendees can view abstracts starting on 01/19/2019
Registered attendees can view abstracts starting on 01/19/2019
Benjamin P. Kleinstiver,
Massachusetts General Hospital, USA
Engineered CRISPR Nucleases to Enhance Genome Editing
Engineered CRISPR Nucleases to Enhance Genome Editing
Andrew May,
Chan Zuckerberg Biohub, USA
DNA Repair Outcomes Provide Insight into Genome Editing Mechanisms in Primary Cell Systems
DNA Repair Outcomes Provide Insight into Genome Editing Mechanisms in Primary Cell Systems
Osamu Nureki,
University of Tokyo, Japan
Structure and Mechanism of RNA-Programmable Nucleases
Structure and Mechanism of RNA-Programmable Nucleases
Short Talk(s) Chosen from Abstracts
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
08:30—11:30
Danwei Huangfu,
Memorial Sloan Kettering Cancer Institute, USA
Human Pluripotent Stem Cells as Models for Genetic Disease
Human Pluripotent Stem Cells as Models for Genetic Disease
Knut Woltjen,
CiRA, Kyoto University, Japan
Isogenic Models of Disease from Induced Pluripotent Stem Cells
Isogenic Models of Disease from Induced Pluripotent Stem Cells
Coffee Break
Amy J. Wagers,
Harvard University, USA
Gene Editing in Stem Cells
Gene Editing in Stem Cells
Erika Sasaki,
Central Institute for Experimental Animals, Japan
Talk Title to be Announced
Talk Title to be Announced
Short Talk(s) Chosen from Abstracts
14:30—16:30
Workshop 2: Delivery Methods
A collection of short talks chosen from the abstracts describing methods and approaches for in vitro and in vivo delivery of genome engineering technologies. The workshop would cover topics including devices for electroporation, mechanical introduction of molecules into cells, cell-specific targeting, viruses and viral-like particles, nanoparticles to address the key need to develop delivery vehicles for effective use of genome engineering approaches in therapeutics and research models.
Short Talks Chosen from Abstracts
17:00—19:00
Design and Engineering of Cellular Devices
Registered attendees can view abstracts starting on 01/19/2019
Registered attendees can view abstracts starting on 01/19/2019
Timothy K. Lu,
Massachusetts Institute of Technology, USA
Synthetic Gene Circuits for Next-Generation Therapeutics
Synthetic Gene Circuits for Next-Generation Therapeutics
Short Talk(s) Chosen from Abstracts
08:30—11:30
Genome Editing Screens for Function and Disease Mechanisms
Registered attendees can view abstracts starting on 01/19/2019
Registered attendees can view abstracts starting on 01/19/2019
Fyodor D. Urnov,
Altius Institute for Biomedical Sciences, USA
Editing Human Genome Control Circuits to Reveal Disease Mechanisms and Targets for Intervention in the Clinic
Editing Human Genome Control Circuits to Reveal Disease Mechanisms and Targets for Intervention in the Clinic
Jan E. Carette,
Stanford University, USA
CRISPR-Cas Screens for Studying Virus-Host Interactions
CRISPR-Cas Screens for Studying Virus-Host Interactions
Coffee Break
Speaker to be Announced
Brittany Adamson,
University of California, San Francisco, USA
Early Career Talk: Perturb-Seq: Combining High throughput CRISPR Screening with Single-Cell Sequencing
Early Career Talk: Perturb-Seq: Combining High throughput CRISPR Screening with Single-Cell Sequencing
Short Talk(s) Chosen from Abstracts
17:00—19:00
Harnessing DNA Repair Mechanisms for Genome Engineering
Registered attendees can view abstracts starting on 01/19/2019
Registered attendees can view abstracts starting on 01/19/2019
Maria Jasin,
Memorial Sloan Kettering Cancer Center, USA
Homologous Recombination and End-Joining Mechanisms in Genome Editing
Homologous Recombination and End-Joining Mechanisms in Genome Editing
Beeke Wienert,
UC Berkeley, USA
Unbiased Identification of CRISPR Off Targets in vivo using DISCOVER-seq
Unbiased Identification of CRISPR Off Targets in vivo using DISCOVER-seq
Nancy Maizels,
University of Washington School of Medicine, USA
Gene Correction at Targeted DNA Breaks
Gene Correction at Targeted DNA Breaks
Short Talk(s) Chosen from Abstracts
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
08:30—11:30
Genome Engineering of Bacteria for Therapeutic and Diagnostic Applications
Registered attendees can view abstracts starting on 01/19/2019
Registered attendees can view abstracts starting on 01/19/2019
Rodolphe Barrangou,
North Carolina State University, USA
Engineered Lactobacilli for Human Health Applications
Engineered Lactobacilli for Human Health Applications
Jason M. Peters,
University of Wisconsin-Madison, USA
Bacterial CRISPRi Screens to Identify the Mode of Action of Novel Antibiotics
Bacterial CRISPRi Screens to Identify the Mode of Action of Novel Antibiotics
Coffee Break
Richard P. Novick†,
New York University, USA
Talk Title to be Announced
Talk Title to be Announced
Short Talk(s) Chosen from Abstracts
14:30—16:30
Workshop 3: Clinical Development Progress
A collection of both invited speakers and speakers selected from the abstracts focused on the current status of clinical trials using genome editing systems.
Short Talks Chosen from Abstracts
17:00—18:45
Genome Editing for Treating Human Disease
Registered attendees can view abstracts starting on 01/19/2019
Registered attendees can view abstracts starting on 01/19/2019
Bruce R. Conklin,
Gladstone Institutes, USA
Genome Surgery for Treating Neuronal Disorders
Genome Surgery for Treating Neuronal Disorders
Paula M. Cannon,
University of Southern California, Keck School of Medicine, USA
Genome Editing to Treat Hematopoietic Disorders and Infectious Diseases
Genome Editing to Treat Hematopoietic Disorders and Infectious Diseases
Michel Sadelain,
Memorial Sloan Kettering Cancer Center, USA
Genome Edited CAR-T Cells for Improved Treatment of Solid Tumors
Genome Edited CAR-T Cells for Improved Treatment of Solid Tumors
Juan Carlos Izpisua-Belmonte,
The Salk Institute for Biological Studies, USA
Engineering Stem Cells in vivo for Therapeutic Benefit
Engineering Stem Cells in vivo for Therapeutic Benefit
Short Talk Chosen from Abstracts
18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/19/2019
Registered attendees can view abstracts starting on 01/19/2019
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.
*Session Chair †Invited, not yet responded.
Keystone Symposia thanks our Sponsors for generously supporting this meeting:
|
BlueRock Therapeutics |
|
|
|
We gratefully acknowledge additional support from these exhibitors at this conference:
|
Horizon Discovery |
Please stop by to meet these exhibitors during the conference.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:
Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:
Click here to view more of these organizations
|
If your organization is interested in joining these entities in support of Keystone
Symposia, please contact: Sarah Lavicka,
Director of Development, Email: sarahl@keystonesymposia.org, Phone:+1 970-262-2690 Click here for more information on Industry Support and Recognition Opportunities. If you are interested in becoming an advertising/marketing in-kind partner, please contact: Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org, Phone:+1 970-262-2676 |
